Clinical Trial Update: A Study of CBT-1 and Paclitaxel With Carboplatin in Patients With Advanced Inoperable Non-small Cell Lung Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating CBT-1 in combination with Paclitaxel and Carboplatin for advanced, inoperable Non-Small Cell Lung Cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• CBT-1
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: CBA Research | Conditions: Non-Small Cell Lung Cancer | Phase 3 | Status: TERMINATED